# FDA recall D-1217-2018

> **Boehringer Ingelheim Pharmaceuticals, Inc.** · Class II · drug recall initiated 2018-09-04.

## Product

Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim  (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18

## Reason for recall

Cross Contamination With Other Products:

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1217-2018
- **Recalling firm:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-09-04
- **Report date:** 2018-10-03
- **Termination date:** 2019-08-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ridgefield, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1217-2018

## Citation

> AI Analytics. FDA recall D-1217-2018. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1217-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*